DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-1.5%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.63B
AUM Growth
+$5.63B
(+18%)
Cap. Flow
+$590M
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
167
New
29
Increased
30
Reduced
12
Closed
23
Top Buys
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$250M |
| 2 |
AdaptHealth
AHCO
|
$139M |
| 3 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
$129M |
| 4 |
Organogenesis Holdings
ORGO
|
$70.2M |
| 5 |
QuidelOrtho
QDEL
|
$52.4M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$110M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 3 |
Biogen
BIIB
|
$86.7M |
| 4 |
Centene
CNC
|
$72.2M |
| 5 |
The Oncology Institute
TOI
|
$54.3M |
Sector Composition
| 1 | Healthcare | 68.23% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Galapagos
GLPG
$2.06B
| $45.3M | 0.8% |
+657,005
| New | +$45.3M |
|
27
BioCryst Pharmaceuticals
BCRX
$1.74B
| $44.8M | 0.8% |
2,835,000
+229,620
| +9% | +$3.63M |
|
28
Werewolf Therapeutics
HOWL
$62.6M
| $44.5M | 0.79% |
+2,552,787
| New | +$44.5M |
|
|
APR
29
DELISTED
Apria, Inc. Common Stock
APR
| $44M | 0.78% |
1,572,892
+372,892
| +31% | +$10.4M |
|
|
ONCR
30
DELISTED
Oncorus, Inc.
ONCR
| $43.5M | 0.77% |
3,148,977
| – | – |
|
|
RETA
31
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $42.5M | 0.75% |
300,000
-120,000
| -29% | -$17M |
|
32
Owens & Minor
OMI
$423M
| $42.2M | 0.75% |
996,500
-552,500
| -36% | -$23.4M |
|
33
Rhythm Pharmaceuticals
RYTM
$6.75B
| $39M | 0.69% |
1,989,625
| – | – |
|
34
Kura Oncology
KURA
$732M
| $37.4M | 0.66% |
+1,794,000
| New | +$37.4M |
|
|
INZY
35
DELISTED
Inozyme Pharma
INZY
| $37.1M | 0.66% |
2,178,985
+214,985
| +11% | +$3.66M |
|
|
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $36.4M | 0.65% |
5,767,409
| – | – |
|
37
Puma Biotechnology
PBYI
$258M
| $34.6M | 0.61% |
3,769,795
| – | – |
|
|
BDSI
38
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $34.1M | 0.61% |
9,530,000
| – | – |
|
39
Nuvation Bio
NUVB
$1.08B
| $33.3M | 0.59% |
3,577,233
+577,233
| +19% | +$5.37M |
|
40
Wave Life Sciences
WVE
$1.27B
| $32.2M | 0.57% |
4,829,069
+1,326,099
| +38% | +$8.83M |
|
|
VIVO
41
DELISTED
Meridian Bioscience Inc
VIVO
| $31.6M | 0.56% |
1,424,274
+535,005
| +60% | +$11.9M |
|
|
ORTX
42
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $30.5M | 0.54% |
6,949,416
| – | – |
|
43
Ardelyx
ARDX
$1.57B
| $28.9M | 0.51% |
3,811,554
+1,250,000
| +49% | +$9.48M |
|
44
Terns Pharmaceuticals
TERN
$651M
| $28.8M | 0.51% |
2,345,959
| – | – |
|
45
CalciMedica
CALC
$45M
| $28.7M | 0.51% |
5,281,713
| – | – |
|
46
Amicus Therapeutics
FOLD
$2.42B
| $28.4M | 0.5% |
2,941,492
+242,995
| +9% | +$2.34M |
|
|
ITMR
47
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $28.1M | 0.5% |
1,193,803
| – | – |
|
|
LENZ
48
LENZ Therapeutics
LENZ
$1.12B
| $27.9M | 0.49% |
+906,308
| New | +$27.9M |
|
|
XLRN
49
DELISTED
Acceleron Pharma Inc.
XLRN
| $27.5M | 0.49% |
219,500
| – | – |
|
50
PMV Pharmaceuticals
PMVP
$82.1M
| $27.5M | 0.49% |
804,000
+380,320
| +90% | +$13M |
|